drugset / Trial / NCT04261517
Efficacy and Safety of Hydroxychloroquine for Treatment of COVID-19
RandomizedParallel-groupOpen-labelTreatment
Summary
The study aims to evaluate the efficacy and safety of hydroxychloroquine in the treatment of COVID-19 pneumonia.
Timeline
- Start
- 2020-02-06
- Primary completion
- 2020-02-25
- Completion
- 2020-02-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hydroxychloroquine | Small molecule | 400 mg | Oral |